Table 1.
Baseline characteristics of the study population
| Characteristics | N (%) |
|---|---|
| Mean age, N = 1866 | 40(±10) |
| Sex, N = 1866 | |
| Male | 1026 (55.0) |
| Female | 840 (45.0) |
| Religion, N = 1851 | |
| Christian | 1744 (94.2) |
| Muslim | 107 (5.8) |
| Calendar Year, N = 1866 | |
| < 2005 | 494 (26.5) |
| 2005–2009 | 717 (38.4) |
| ≥ 2010 | 655 (35.1) |
| Cotrimoxazole, N = 1861 | |
| No | 420 (22.6) |
| Yes | 1441 (77.4) |
| ARV, N = 1861 | |
| No | 1426 (76.6) |
| Yes | 435 (23.4) |
| WHO stage, N = 1860 | |
| Stage1 | 297 (15.9) |
| Stage2 | 480 (25.8) |
| Stage3 | 598 (32.2) |
| Stage4 | 485 (26.0) |
| Marital status, N = 1866 | |
| Single | 643 (34.5) |
| Married | 1012 (54.2) |
| Divorced + Widowed | 211 (11.3) |
| Employment, N = 1866 | |
| Employed | 1271 (68.1) |
| Unemployed | 522 (27.9) |
| Student | 73 (4.0) |
| Circumstances of diagnosis, N = 1865 | |
| Routine screening | 311 (16.7) |
| PMTCT program | 81 (4.3) |
| Blood donation | 8 (0.4) |
| HIV positive partner | 119 (6.4) |
| Clinical suspicion | 1346 (72.2) |
| CD4+ T cell count, N = 1866 | |
| < 50 cells/mm3 | 384 (20.6) |
| 50–199 cells/mm3 | 804 (43.1) |
| 200–349 cells/mm3 | 392 (21.2) |
| ≥ 350 cells/mm3 | 282 (15.1) |
| Time of first CD4+ T cell test, N = 1858 | |
| The day of diagnosis | 166 (8.9) |
| Within 3 months | 1661 (89.4) |
| > 3 months | 31 (1.7) |
Results are presented as count (percentage) or otherwise stated. ARV and Cotrimoxazole started at presentation
PMTCT Prevention of mother to child transmission program